The Cell Biology of HIV-1 Genome Trafficking

HIV-1 基因组贩运的细胞生物学

• 批准号: 10404088
• 负责人: Nathan M Sherer
• 金额: $ 38.21万
• 依托单位: UNIVERSITY OF WISCONSIN-MADISON
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-01-15 至 2024-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10404088
• 关键词: AIDS/HIV problem; Address; Architecture; Behavior; Betaretrovirus; Binding; Biochemical; Biological Assay; Biosensor; Cell Nucleus; Cell membrane; Cells; Cellular biology; Cessation of life; Complex; Cytoplasm; Development; Diffusion; Dimerization; Dissection; Distant; Electron Microscopy; Elements; Ensure; Event; Exhibits; Exposure to; Face; Funding; Gene Expression; Genetic Transcription; Genome; Goals; HIV Genome; HIV-1; Human; Infection; Integration Host Factors; Intervention; Kinetics; Length; Life; Link; Mason-Pfizer monkey virus; Mediating; Microtubules; Motor; Mus; Nuclear; Nuclear Accidents; Nuclear Envelope; Nuclear Export; Nuclear Pore; Nuclear RNA; Pathway interactions; Peripheral; Persons; Production; Proteomics; Proviruses; RNA; RNA Transport; RNA delivery; RNA-Binding Proteins; Reporter; Research; Resolution; Response Elements; Retroviridae; Rodent; Series; Site; Testing; Therapeutic; Time; Translations; Viral; Viral Genes; Viral Genome; Virion; Virus; Visual; acute infection; base; cellular imaging; chronic infection; comparative; high resolution imaging; imaging modality; in vivo; innovation; light microscopy; live cell imaging; mRNA Precursor; nanometer; novel virus; nucleocytoplasmic transport; programs; quantitative imaging; receptor; rev Protein; spatiotemporal; therapy development; tool; trafficking; viral RNA; virus host interaction

PROJECT SUMMARY / ABSTRACT More than 36 million people worldwide are living with HIV-1 infection as of 2017, with HIV/AIDS causing ~1 million deaths per year. HIV-1 establishes a life-long, persistent infection. There are no therapies yet capable of permanently suppressing viral gene expression in the context of acute infection or latency rebound. This project’s long-term goal is to elucidate the cellular mechanisms that underpin HIV-1 RNA subcellular trafficking, translation, and genome packaging toward the development of therapies to selectively abrogate these stages in vivo. In the current funding period we elucidated cell-intrinsic barriers to HIV-1 genome nuclear export in cells derived from mice and other rodents. We also developed cutting- edge, quantitative imaging strategies for studying HIV-1 viral RNA (vRNA) trafficking and virus particle assembly dynamics in human cells. Collectively, these studies revealed that cooperative interactions between discrete cis-acting viral RNA structural elements and defined RNA binding proteins program vRNAs for striking transport behaviors both in the nucleus and cytoplasm. For example, we found that HIV- 1’s Rev response element (RRE), regulated by the viral Rev protein and cellular XPO1 nuclear export receptor, dictates a previously unanticipated 3-step vRNA transport pathway characterized by transient subnuclear compartmentalization events, “burst” nuclear export kinetics, and diffusion to peripheral sites of translation and genome packaging in the cytoplasm. Herein we test the overarching hypothesis that HIV-1 is adapted to exploit XPO1-mediated “burst” export in order to ensure rapid, non-linear increases to viral late stage gene expression and to promote the efficient delivery of viral genomes to virion assembly sites at the cell periphery. The goal of Specific Aim 1 is to define the nuclear membrane events that underpin XPO1-directed “burst” vRNA nuclear export using advanced high-resolution imaging modalities. Specific Aim 2 applies a comparative visual and biochemical approach to define conserved features of XPO1-linked vRNA export modules in the context of broad-spectrum antiviral targeting. Specific Aim 3 uses cell-based assays and new HIV-1 reporter viruses to study the links between “burst” export at the nucleus and cytoplasmic events including Gag/Gag-Pol translation, genome packaging, and virus particle assembly. Collectively, these detailed studies are intended to expose new cell biology, deliver innovative tools for studying viruses, and identify novel virus-host interactions relevant to the development of therapies to suppress HIV-1 virion production in vivo.

项目摘要/摘要 截至2017年，全球有超过3600万人感染艾滋病毒-1，艾滋病毒/艾滋病导致 每年约有100万人死亡。HIV-1建立了一种终生、持续的感染。目前还没有治疗方法 能够在急性感染或潜伏的情况下永久抑制病毒基因的表达 抢篮板球。该项目的长期目标是阐明支撑HIV-1RNA的细胞机制 亚细胞运输、翻译和基因组包装，以开发治疗 在体内选择性地取消这些阶段。在目前的资助期间，我们阐明了细胞固有的障碍。 小鼠和其他啮齿动物来源的细胞中的HIV-1基因组核输出。我们还开发了切割- 研究HIV-1病毒RNA(VRNA)转运和病毒颗粒的边缘、定量成像策略 人类细胞中的组装动力学。总体而言，这些研究表明，合作互动 离散的顺式作用病毒RNA结构元件与已定义的RNA结合蛋白程序之间的关系 VRNAs在细胞核和细胞质中都有显著的运输行为。例如，我们发现艾滋病毒- 受病毒REV蛋白和细胞XPO1核输出调控的1‘S REV反应元件 受体，决定了以前未曾预料到的三步vRNA转运途径，其特征是瞬时 亚核区划事件、“爆发式”核出口动力学和扩散到外围地点 细胞质中的翻译和基因组包装。在这里，我们检验了压倒一切的假设 HIV-1适用于利用XPO1介导的“突发”输出，以确保快速、非线性地增加到 病毒晚期基因表达和促进病毒基因组高效传递到病毒粒子组装 位于细胞外围的位置。具体目标1的目标是定义核膜事件 使用先进的高分辨率成像方式，支持XPO1引导的vRNA核输出。 特定目标2应用比较视觉和生化方法来定义 在广谱抗病毒靶向的背景下，XPO1连接的vRNA输出模块。具体目标3 使用基于细胞的分析和新的HIV-1报告病毒来研究在 细胞核和细胞质事件，包括Gag/Gag-Pol翻译、基因组包装和病毒颗粒 集合。总的来说，这些详细的研究旨在揭示新的细胞生物学，提供创新的 研究病毒的工具，并确定与发展相关的新的病毒-宿主相互作用 抑制体内HIV-1病毒粒子产生的治疗方法。